Advanced in Hemolytic Anemia
Advanced in Hemolytic Anemia
8017 Glengalen Ln, 
Chevy Chase, MD 

Overview

Gary Crouch is a Pediatric Hematologist Oncology provider in Chevy Chase, Maryland. Dr. Crouch is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Sickle Cell Disease, Hereditary Spherocytosis, Hemophilia A, Hemophilic Arthropathy, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 15 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hemolytic Anemia.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in MS
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

8017 Glengalen Ln, Chevy Chase, MD 20815

Additional Areas of Focus

Dr. Crouch has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


15 Clinical Trials

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
View 10 Less Clinical Trials
Similar Doctors
Elite in Hemolytic Anemia
Pediatric Hematology Oncology
Elite in Hemolytic Anemia
Pediatric Hematology Oncology
10 Center Dr, Building 10crc, Rm 5-5140, 
Bethesda, MD 
 (2.1 miles away)
Languages Spoken:
English

Gregory Kato is a Pediatric Hematologist Oncology provider in Bethesda, Maryland. Dr. Kato is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Elite in Hemolytic Anemia
Pediatric Hematology Oncology
Elite in Hemolytic Anemia
Pediatric Hematology Oncology
111 Michigan Ave Nw, 
Washington, DC 
 (5.4 miles away)
Languages Spoken:
English

Caterina Minniti is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Minniti is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Elite in Hemolytic Anemia
Pediatric Hematology Oncology
Elite in Hemolytic Anemia
Pediatric Hematology Oncology

Children's Hospital

111 Michigan Ave Nw, 
Washington, DC 
 (5.4 miles away)
Languages Spoken:
English

Deepika Darbari is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Darbari is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Crouch's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 17 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile